TW200738693A - Substituted biaryls, process for their manufacture and use thereof as medicaments - Google Patents

Substituted biaryls, process for their manufacture and use thereof as medicaments

Info

Publication number
TW200738693A
TW200738693A TW095131511A TW95131511A TW200738693A TW 200738693 A TW200738693 A TW 200738693A TW 095131511 A TW095131511 A TW 095131511A TW 95131511 A TW95131511 A TW 95131511A TW 200738693 A TW200738693 A TW 200738693A
Authority
TW
Taiwan
Prior art keywords
medicaments
manufacture
substituted biaryls
salts
biaryls
Prior art date
Application number
TW095131511A
Other languages
English (en)
Chinese (zh)
Inventor
Georg Dahmann
Kai Gerlach
Roland Pfau
Henning Priepke
Wolfgang Wienen
Herbert Nar
Annette Schuler-Metz
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35559394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200738693(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TW200738693A publication Critical patent/TW200738693A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW095131511A 2005-08-29 2006-08-28 Substituted biaryls, process for their manufacture and use thereof as medicaments TW200738693A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107891 2005-08-29

Publications (1)

Publication Number Publication Date
TW200738693A true TW200738693A (en) 2007-10-16

Family

ID=35559394

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095131511A TW200738693A (en) 2005-08-29 2006-08-28 Substituted biaryls, process for their manufacture and use thereof as medicaments

Country Status (3)

Country Link
AR (1) AR057976A1 (de)
TW (1) TW200738693A (de)
WO (1) WO2007025940A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2565437A1 (en) 2004-06-18 2006-01-05 Millennium Pharmaceuticals, Inc. Factor xa inhibitors
US7696352B2 (en) * 2004-06-18 2010-04-13 Millennium Pharmaceuticals, Inc. Factor Xa inhibitors
JP5227311B2 (ja) * 2006-05-05 2013-07-03 ミレニアム ファーマシューティカルズ， インコーポレイテッド 第Ｘａ因子阻害剤
MX2009001877A (es) * 2006-08-21 2009-03-02 Synta Pharmaceuticals Corp Compuestos para el tratamiento de trastornos proliferativos.
DE102007028319A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
EP2220079A2 (de) 2007-11-15 2010-08-25 Boehringer Ingelheim International GmbH Substituierte amide sowie ihre herstellung und verwendung als medikamente
WO2009063029A2 (en) * 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US8263630B2 (en) 2008-02-12 2012-09-11 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type I inhibitors
EP2140866A1 (de) * 2008-07-04 2010-01-06 Bayer Schering Pharma Aktiengesellschaft Oxazolidinone zur Behandlung von Entzündungserkrankungen des Magen-Darm-Trakts
US8742120B2 (en) 2009-12-17 2014-06-03 Millennium Pharmaceuticals, Inc. Methods of preparing factor xa inhibitors and salts thereof
WO2011084652A2 (en) * 2009-12-17 2011-07-14 Millennium Pharmaceuticals, Inc. Salts and crystalline forms of a factor xa inhibitor
EP3078378B1 (de) 2015-04-08 2020-06-24 Vaiomer Verwendung von faktor-xa-inhibitoren zur regulierung von glykämie
CN111116483B (zh) * 2019-11-25 2022-12-20 浙江师范大学 一种2-咪唑基咪唑类化合物及其制备方法
JP2023509452A (ja) 2020-01-03 2023-03-08 バーグ エルエルシー がんを処置するためのｕｂｅ２ｋモジュレータとしての多環式アミド

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725244D0 (en) * 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10254336A1 (de) * 2002-11-21 2004-06-03 Merck Patent Gmbh Carbonsäureamide

Also Published As

Publication number Publication date
AR057976A1 (es) 2008-01-09
WO2007025940A1 (de) 2007-03-08

Similar Documents

Publication Publication Date Title
TW200738693A (en) Substituted biaryls, process for their manufacture and use thereof as medicaments
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
MY146623A (en) Substituted prolinamides, manufacturing, and the use thereof as medicaments
WO2009065919A3 (de) Organische verbindungen
WO2009065920A3 (de) Verbindungen
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2007036532A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2006021379A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2006021378A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2005103037A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2008116107A3 (en) Piperazine derivatives as glucokinase activators
WO2009065922A3 (de) Organische verbindungen
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
SG169337A1 (en) Aryl sulfonamides with an analgesic action
MY148769A (en) Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
MX2010004669A (es) Proceso para la preparacion de derivados de isoindol asi como tambien un proceso para la preparacion de sus intermediarios.
MX2008012332A (es) Tiazolil-dihidro-indazoles.
TN2010000072A1 (en) New compounds
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2009034029A3 (de) 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten
WO2007048841A3 (de) Neue indol-haltige beta-agonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
TW200740798A (en) Substituted amides, process for their manufacture and use thereof as medicaments
WO2008135525A3 (en) Substituted azetidines, manufacturing and use thereof as medicaments
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents